ReviewThe oncologist2023

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.

Stefania Morganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.